Brainsway Ltd
BWAY15.590USD
0.000
終値 11/07, 16:00（ET）15分遅れの株価
589.14M時価総額
110.24直近12ヶ月PER
詳細情報 Brainsway Ltd 企業名
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Brainsway Ltdの企業情報
企業コードBWAY
会社名Brainsway Ltd
上場日Dec 24, 2006
最高経営責任者「CEO」Mr. Hadar Levy
従業員数120
証券種類Ordinary Share
決算期末Dec 24
本社所在地16 Hartum Street Rad Tower, 14Th Floor
都市JERUSALEM
証券取引所Tel Aviv Stock Exchange
国Israel
郵便番号9777516
電話番号97225813140
ウェブサイトhttps://www.brainsway.com/
企業コードBWAY
上場日Dec 24, 2006
最高経営責任者「CEO」Mr. Hadar Levy
Brainsway Ltdの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Colleen A. Hanlon, Ph.D.
Dr. Colleen A. Hanlon, Ph.D.
Vice President - Medical Affairs
Vice President - Medical Affairs
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Prof. Abraham Zangen, Ph.D.
Prof. Abraham Zangen, Ph.D.
Director
Director
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Amiram (Ami) Boehm
Mr. Amiram (Ami) Boehm
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Colleen A. Hanlon, Ph.D.
Dr. Colleen A. Hanlon, Ph.D.
Vice President - Medical Affairs
Vice President - Medical Affairs
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Prof. Abraham Zangen, Ph.D.
Prof. Abraham Zangen, Ph.D.
Director
Director
--
--
Mr. Ido Marom
Mr. Ido Marom
Chief Financial Officer
Chief Financial Officer
--
--
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2024
FY2023
FY2022
FY2021
FY2020
データなし
地域別USD
会社名
収益
比率
United States
33.23M
81.01%
Other
7.79M
18.99%
事業別
地域別
データなし
株主
更新時刻: Sat, Aug 16
更新時刻: Sat, Aug 16
株主統計
種類
株主統計
株主統計
比率
Valor Equity Partners
13.59%
Masters Capital Management, L.L.C.
5.11%
Phoenix Financial Ltd
3.56%
Acadian Asset Management LLC
1.71%
Essex Investment Management Company, LLC
1.59%
他の
74.44%
株主統計
株主統計
比率
Valor Equity Partners
13.59%
Masters Capital Management, L.L.C.
5.11%
Phoenix Financial Ltd
3.56%
Acadian Asset Management LLC
1.71%
Essex Investment Management Company, LLC
1.59%
他の
74.44%
種類
株主統計
比率
Private Equity
13.98%
Hedge Fund
9.39%
Investment Advisor/Hedge Fund
4.73%
Holding Company
3.67%
Investment Advisor
3.47%
Individual Investor
2.69%
Pension Fund
0.45%
Research Firm
0.31%
他の
61.30%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
83
5.59M
28.96%
-873.84K
2025Q2
82
7.33M
38.85%
+597.38K
2025Q1
84
7.36M
38.96%
-890.13K
2024Q4
77
7.26M
38.54%
-2.72M
2024Q3
65
3.62M
21.68%
-5.03M
2024Q2
59
4.49M
26.92%
-3.10M
2024Q1
56
4.64M
27.89%
-3.35M
2023Q4
48
4.90M
29.50%
-2.87M
2023Q3
43
4.53M
27.32%
-3.32M
2023Q2
45
4.62M
27.86%
-2.51M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Valor Equity Partners
2.10M
11.07%
--
--
Jun 30, 2025
Masters Capital Management, L.L.C.
1.00M
5.26%
--
--
Jun 30, 2025
Phoenix Financial Ltd
697.26K
3.67%
+456.90K
+190.09%
Oct 18, 2024
Acadian Asset Management LLC
334.27K
1.76%
-2.31K
-0.69%
Jun 30, 2025
Essex Investment Management Company, LLC
300.94K
1.58%
-2.23K
-0.73%
Jun 30, 2025
Renaissance Technologies LLC
283.86K
1.49%
-14.40K
-4.83%
Jun 30, 2025
Shulkin (Jonathan K.)
268.25K
1.41%
+268.25K
--
Nov 05, 2024
Gracias (Antonio J)
243.50K
1.28%
+243.50K
--
Nov 05, 2024
ARK Investment Management LLC
199.83K
1.05%
+11.50K
+6.11%
Jun 30, 2025
Two Sigma Investments, LP
172.60K
0.91%
+1.82K
+1.07%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
ActivePassive International Equity ETF
0.04%
ARK Israel Innovative Technology ETF
0%
iShares Neuroscience and Healthcare ETF
0%
ActivePassive International Equity ETF
比率0.04%
ARK Israel Innovative Technology ETF
比率0%
iShares Neuroscience and Healthcare ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
